Bluestone JA - Search Results

1

Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.

Sneddon JB, Tang Q, Stock P, Bluestone JA, Roy S, Desai T, Hebrok M. Sneddon JB, et al. Among authors: bluestone ja. Cell Stem Cell. 2018 Jun 1;22(6):810-823. doi: 10.1016/j.stem.2018.05.016. Cell Stem Cell. 2018. PMID: 29859172 Free PMC article. Review.

2

The Src family kinase Fyn mediates signals induced by TCR antagonists.

Tang Q, Subudhi SK, Henriksen KJ, Long CG, Vives F, Bluestone JA. Tang Q, et al. Among authors: bluestone ja. J Immunol. 2002 May 1;168(9):4480-7. doi: 10.4049/jimmunol.168.9.4480. J Immunol. 2002. PMID: 11970992

3

Immunotherapy of insulin-dependent diabetes mellitus.

Masteller EL, Bluestone JA. Masteller EL, et al. Among authors: bluestone ja. Curr Opin Immunol. 2002 Oct;14(5):652-9. doi: 10.1016/s0952-7915(02)00375-8. Curr Opin Immunol. 2002. PMID: 12183168 Review.

4

CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.

Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. Bour-Jordan H, et al. Among authors: bluestone ja. Nat Immunol. 2003 Feb;4(2):182-8. doi: 10.1038/ni884. Epub 2003 Jan 13. Nat Immunol. 2003. PMID: 12524538

5

Beta-cell replacement for type I diabetes.

Stock PG, Bluestone JA. Stock PG, et al. Among authors: bluestone ja. Annu Rev Med. 2004;55:133-56. doi: 10.1146/annurev.med.55.091902.103539. Annu Rev Med. 2004. PMID: 14746513 Review.

6

Regulated beta-cell regeneration in the adult mouse pancreas.

Cano DA, Rulifson IC, Heiser PW, Swigart LB, Pelengaris S, German M, Evan GI, Bluestone JA, Hebrok M. Cano DA, et al. Among authors: bluestone ja. Diabetes. 2008 Apr;57(4):958-66. doi: 10.2337/db07-0913. Epub 2007 Dec 14. Diabetes. 2008. PMID: 18083786

7

Safer, longer-lasting regulatory T cells with beta-catenin.

Bluestone JA, Hebrok M. Bluestone JA, et al. Nat Med. 2008 Feb;14(2):118-9. doi: 10.1038/nm0208-118. Nat Med. 2008. PMID: 18256611 No abstract available.

8

2008 Update from the Collaborative Islet Transplant Registry.

Alejandro R, Barton FB, Hering BJ, Wease S; Collaborative Islet Transplant Registry Investigators. Alejandro R, et al. Transplantation. 2008 Dec 27;86(12):1783-8. doi: 10.1097/TP.0b013e3181913f6a. Transplantation. 2008. PMID: 19104422

9

Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function.

Villalta SA, Lang J, Kubeck S, Kabre B, Szot GL, Calderon B, Wasserfall C, Atkinson MA, Brekken RA, Pullen N, Arch RH, Bluestone JA. Villalta SA, et al. Among authors: bluestone ja. Diabetes. 2013 Aug;62(8):2870-8. doi: 10.2337/db12-1619. Epub 2013 Jul 8. Diabetes. 2013. PMID: 23835340 Free PMC article.

10

Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm.

Szot GL, Yadav M, Lang J, Kroon E, Kerr J, Kadoya K, Brandon EP, Baetge EE, Bour-Jordan H, Bluestone JA. Szot GL, et al. Among authors: bluestone ja. Cell Stem Cell. 2015 Feb 5;16(2):148-57. doi: 10.1016/j.stem.2014.12.001. Epub 2014 Dec 18. Cell Stem Cell. 2015. PMID: 25533131 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

535 results

Search Page